description Today, refer of reported Thank third changes to comments so release everyone. for our results. in Ellen, focus the adjusted a earnings press today's and year-over-year I'll morning, on detailed please measures, our you, quarter my good
price. X% a revenue, in constant billion $X.XXX a delivered we decline with decline nine, in X% currency, in slide on Starting X% or growth
exchange our expectations the represented guidance. $XX with million quarter in X%, headwind line a August rates Foreign of in in or
Slide XX slide revenue region breaks provides quarter. performance our by species down revenue XX the in by and
we portfolio, in by growth For parasiticides partially growth our in declined price offset for Health, the portfolio. volume X% constant declines our quarter, in with Pet and currency X% pain
pressure. X% to business US retail last declined Our compared due competitive to and overall primarily channel year,
driven international currency, constant in slowdown the business primarily Europe. X% by declined economic Our in
quarter. year-over-year in second flat performance, of August While our our lower in currency than was the X% constant was globally with decline it overall expectations significantly line quarter approximately the for
economic slowdown driven by macro-driven impacting in global in US and of the the channel. The retail the underperformance restrictions to the was Europe as our as from accelerating China impacts guidance macro pressures well continuation
to respectively, US, key of shows to available quarter, retailer third economic-driven and retail believe and lower in options; parasiticides market the products the across from prescription there currency, down OTC In We million constant treatment market and this; $XX categories; In million. XX% the $X overall. Advantage declined management broader and Seresto three data options. consumer competition the and driving behavior the family XX% from moving trends or cost inventory are prevention for
inflation. emerged, the is the year-over-year economic the energy that by driven US, has we decline primarily consumer costs Outside believe Europe in and from higher slowdown
we into price expect the of packaging issues XD cats. for On paper like family, remediated availability both stabilization this expanded from and XXXX and improvement, and of Advantage the return year, for earlier for physical going Seresto innovations a we constant supply currency introduction opportunities Advantage driven by basis,
respond monitor dynamics will these macro to to markets. the We continue in and important
shop points business with they to multiple vet to products believe While in the pressure, complement us effective profitability at core customers retail growth long-term price and pet is provides opportunity our where clinics. market for we experiencing want meeting
earlier. the to for our prescription suggest overall remain mentioned $X globally, US manufacturer the Pet best expect we retail of the the US products that sales a products about Our from annually, XX% time which is and Health parasiticide total of tailwinds over US products portfolio, part estimates market into approximately is OTC In largest market. billion with Ellen
the X% basis, XX%. year-to-date global global And while remains Plus across business the Pet a declined overall, Health constant On parasiticides and franchise dog, business cat challenged grew currency. the in Credelio Credelio
driven the Our Galliprant pain the by outgrowing combination in portfolio US with strong dispensing, market grew launch. in ZORBIUM's year-to-date, continued XX%
price animal in swine in and products the poultry for in For Asia. in constraint farm Both US flat business our our supply strength in US farm offset certain portfolio currency, business the at international and and growth. was flat was quarter, a cattle by Increased demand constant for quarter. aqua vaccines the decline with was animal X% the continued
Rumensin continued constant for in Australia. swine Aqua on Overall, helping primarily offset by continued outperformed and challenges cattle Ruminant’s strong in season expectations currency expectations, to Asia. Poultry a a basis, and outperformed driven in also in sheep our
animal a Elanco's is double-digit and Asia. swine, share swine, holding in line gaining Farm cattle primarily On in our market expectations. with in and in Overall, business offset or Animal aqua growth in partially year-to-date globally, poultry, currency, the US X% decline international farm constant by grew with Elanco in basis, global
sales innovation our Experior positive. track of full remain second, third all negotiations million quarter in compared sales than uptake, customer expectations and reorder Our leading the rates $XXX the doubled August million and more and commercial the sequentially for $XXX to metrics related with continue towards between year. to
offset XXX reported sales, costs Slide financial performance efforts XX line inflation by the costs, margin In declined our productivity decrease and with and partially basis driven in third primarily gross by our and unfavorable points across price. in the improved mix. These manufacturing to XX.X%, product further freight for quarter. footprint input summarizes were conversion
or FX reduction year-over-year the $XXX approximately the a $XX million, impact for or quarter million of were expenses of $XX was favorable benefit XX% year-over-year. The Operating a million. on expenses in X% third quarter
from demonstrated a be integration above as R&D and reasonably respect by Our with spend $XX continues quarter this team to synergies SG&A, our to we productivity continued million mindset tight of range in the deliver year. per restructuring are about pleased to expectations. With actions
legacy own go-live middle into in Animal service shared Health on the system, business the is of accelerated Elanco's and centers XXXX the quarter processes Our second well, Bayer and to from year. we ERP progressing business timing early our of of execution the the of integration the
Adjusted was interest on $X the of from debt. will of provide driven million decline was a rate year-over-year moments. sequential higher few a by rates $X expense I quarter, more on this interest increase portfolio $XX in million. the million, floating details year second our The in the debt quarter
The was from non-GAAP full the effective XX%. rate multiple tax in XX.X% quarter, year quarter. between benefits our non-GAAP and tax now effective XX% resulting We lower expect to rate the for discrete expectations, than the be
million driven in a you productivity statement, $X tax million was income was agenda, lower more EPS stronger and adjusted plus topline by lower down offsetting the $XX our income the of net The negative net the impact than as was Adjusted rate. for quarter. adjusted our of dollar income $X.XX execution the and move increase the
As $XX a to XX% income. the reminder, impact or million falls headwinds in in quarter the foreign net exchange approximately approximately through million $XX topline of
than gross or a Adjusted our third decline a EBITDA was XXX EBITDA X% million our in sales Elanco the with guidance, helped margin the adjusted and initiatives in of decline million productivity midpoint just decline of the about our across reported despite better In expansion X% quarter, $XXX in $XX to profit. XX% points. basis quarter
and the to August. sales lower goods We year it sales last inflation Health expect faced unfavorable mix on has sold. than higher we be more that and to third of the the $XXX shared inflation in Pet the we with declined revenue quarter, had a million profit from we in of result Gross stabilized in over cost continue as line believe the
outlook XXXX Now, on let's to our transition for updated slide XX.
from fourth guidance quarters. we our two sales expect constant in of that August, the would the part currency a As decline of the represent quarter reversal last
because environmental of the guidance are lockdowns by $XXX dollar, and in the Health COVID reducing factors approximately year our US retail impacting million. worsening full Pet However, continued macro US of strength and Europe business, China, our we revenue the
but quarter as let the of first guidance region. the in our X% can in be but provide slowdown half of The on Europe, have bridge In August economic on the context found business the from slide that the XX, pressures intensified. the me X% XXXX, result declined in increased third a
have the region, similar sellout across Elanco's market of top We Pet line Health seen results. in several generally our data the in countries with in
China year. expected we X% decline the August, for In to full
full XX% half, impacting to our the lockdowns, decline However, year, of compared year. in protein pressures our despite are to continued of quarter expectations COVID-XX second a China than for business deceleration the third more Swine profitability us update first China the the August the business and outlook in our the the for be producer half to a of XX% leading decline to the
flea as decline data the lower the available accelerated year-over-year tick shifted reduced in and consumers US over-the-counter sizes in basket shows third has overall, experienced to market, and quarter an Finally, treatment cost channels, options. have retail
can our assumptions to update constant year-over-year be our of largely And we be midpoint. an revenue remain $X.XX slide reflecting rest at bridge between full guidance intact. on $X.XXX XXXX expect from for decline X% billion The expected the year, billion, the and XX. The currency to now August found
the on adjusted reduction As EBITDA be see slide billion million or from range $X.XX billion XX, a and expect August the $XX you from between to XXXX, approximately bridge for can midpoint the guidance. we of our $X.XXX from now
of of third approximately our margin offset gross the operating overachievement, reduction the while The is favorability. the rest lower $X with revenue net reduction, the US quarter drop-through quarter drives the fourth of stronger expected from million dollar expense and
the reduction, other the of by quarter. overachievement offset and which We $X.XX the is approximately dollar range now is productivity by in of our small reduction EPS the amount to $X.XX midpoint adjusted stronger driven diluted compared is of a of guidance. $X.XX XXXX, the US to the while expect driving third for the a reduction, August partially from $X.XX sales $X.XX operational The
Our fourth slide detailed is quarter XX. guidance on
the Finally, to move rate XX-Q slide million quarter, cash file our sheet in we metrics the a reported balance $XXX million, on interest a the but in flow swap net third XX. to days, quarter lower and cash settlement. coming flow reflecting a was benefit of and expect net our the operating cash from let's In $XX the loss year-over-year
the next in cash as quarter in in this settlement second rates volatility The provides a headwind the cash operating that over The will swap years interest flow both in acceleration create cash third the four benefit third to being reverses. position, swaps quarter. and to restructure debt our floating which to in of allowed the for of paydown allowed financial accelerate the the and than the swaps advantage quarters rate benefit take fixed third us greater interest cash money the a
the benefit, swap million cash the Excluding $XX operating third increased of XXXX. quarter over
We the ended with million a reduction of second billion in the compared debt, to quarter $XXX of net $X.XX quarter XXXX.
ratio adjusted debt time. the net Our EBITDA to third X.X the was quarter end at of
our find our repay million slide reducing on current approximately priority. On to expected XX, profile paydown, net can expect by This On debt approximately year, detail debt million million. $XXX to allocation in our and we debt you positions. rate gross capital debt debt $XXX swap primary remain to is position and interest improve $XXX
end X.X is the X.X XXXX. EBITDA leverage the from of year, times to adjusted this expected at end net to be of X.X times Our at down
obligations until our year-end million dollar obligations. The business $XXX to our in balance to limited reduce and $XX XXXX. maturities, in the confident has additional roughly We In of cash continue meet and to remain the debt the impact cash the compared XXXX, and stronger generation ability have million of durability net we by reduced XXXX. with our debt
to With I'll hand that, it back Jeff.
